TrialPanorama/TrialPanorama-database huggingface dataset:
Study: 33249003

Group type: EXPERIMENTAL
Intervention: Lumacaftor/ivacaftor (LUM/IVA)
Number of subjects: 20

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 20
Study: 32878963

Group type: EXPERIMENTAL
Intervention: Ceralasertib + olaparib
Number of subjects: 192

Group type: EXPERIMENTAL
Intervention: Olaparib monotherapy
Number of subjects: 192

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 192
Study: 35704329

Group type: EXPERIMENTAL
Intervention: Licaminlimab (60 mg/mL, 8 drops/day for 15 days, 4 drops/day for 7 days, then matching vehicle for 7 days)
Number of subjects: 43

Group type: COMPARATOR
Intervention: Dexamethasone eye drops (8 drops/day for 15 days, tapering to 1 drop/day over 14 days)
Number of subjects: 43
Study: 33432839

Group type: EXPERIMENTAL
Intervention: Benzodiazepines
Number of subjects: 154

Group type: COMPARATOR
Intervention: Morphine
Number of subjects: 154

Group type: COMPARATOR
Intervention: β‐blockers
Number of subjects: 154

Group type: COMPARATOR
Intervention: Antidepressants
Number of subjects: 154
Study: 35731535

Group type: EXPERIMENTAL
Intervention: Laparoscopic Sleeve Gastrectomy (LSG)
Number of subjects: 240

Group type: COMPARATOR
Intervention: Laparoscopic Roux-en-Y Gastric Bypass (LRYGB)
Number of subjects: 240
Study: 33035599

Group type: EXPERIMENTAL
Intervention: Liraglutide
Number of subjects: 96

Group type: EXPERIMENTAL
Intervention: Insulin glargine
Number of subjects: 96

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 96
Study: 35871917

Group type: EXPERIMENTAL
Intervention: Probiotic yogurt (100 g daily for 6 weeks)
Number of subjects: 66

Group type: COMPARATOR
Intervention: Ordinary yogurt (100 g daily for 6 weeks)
Number of subjects: 66
Study: 32918323

Group type: EXPERIMENTAL
Intervention: zolpidem extended-release (ER)
Number of subjects: 103

Group type: COMPARATOR
Intervention: placebo
Number of subjects: 103
Study: 32711599

Group type: EXPERIMENTAL
Intervention: Nanosilver nasal spray post-surgery
Number of subjects: 112
Study: 35013710

Group type: EXPERIMENTAL
Intervention: Atazanavir/ritonavir (ATV/r) plus hydroxychloroquine
Number of subjects: 108

Group type: COMPARATOR
Intervention: Lopinavir/ritonavir (LPV/r) plus hydroxychloroquine
Number of subjects: 108

Group type: EXPERIMENTAL
Intervention: Both ATV/r and LPV/r
Number of subjects: 108
Study: 33139173

Group type: EXPERIMENTAL
Intervention: Throat pack
Number of subjects: 54

Group type: COMPARATOR
Intervention: Without throat pack
Number of subjects: 54
Study: 32725352

Group type: EXPERIMENTAL
Intervention: 0.2% bupivacaine infusion via mcTAP catheters
Number of subjects: 52

Group type: COMPARATOR
Intervention: Saline infusion via mcTAP catheters (Control)
Number of subjects: 52
Study: 33481452

Group type: EXPERIMENTAL
Intervention: Local anesthesia injection followed by ULB in the right eyelid and then in the left (Group A)
Number of subjects: 40

Group type: EXPERIMENTAL
Intervention: Local anesthesia injection to both eyelids followed by ULB on both eyelids (Group B)
Number of subjects: 40

Group type: COMPARATOR
Intervention: Comparison between Group A and Group B
Number of subjects: 40
Study: 32358782

Group type: EXPERIMENTAL
Intervention: HRV biofeedback (HRVB) training, 4-6 weekly sessions until skill acquisition
Number of subjects: 34

Group type: EXPERIMENTAL
Intervention: HRV biofeedback (HRVB) training
Number of subjects: 34

Group type: COMPARATOR
Intervention: Usual care (control)
Number of subjects: 34
Study: 33021579

Group type: COMPARATOR
Intervention: Traditional Sets (TS; 4 sets of 10 with 95 seconds of interset rest)
Number of subjects: 11

Group type: EXPERIMENTAL
Intervention: Rest-Redistribution (RR; 20 sets of 2 with 15 seconds of interset rest)
Number of subjects: 11
Study: 34148297

Group type: EXPERIMENTAL
Intervention: Test cefradine capsules (250 mg single dose) under fasting conditions
Number of subjects: 0

Group type: COMPARATOR
Intervention: Reference cefradine capsules (250 mg single dose) under fasting conditions
Number of subjects: 0

Group type: EXPERIMENTAL
Intervention: Test cefradine capsules (250 mg single dose) under fed conditions
Number of subjects: 0

Group type: COMPARATOR
Intervention: Reference cefradine capsules (250 mg single dose) under fed conditions
Number of subjects: 0
Study: 32054486

Group type: EXPERIMENTAL
Intervention: TFD containing 140 mg of caffeine
Number of subjects: 32

Group type: EXPERIMENTAL
Intervention: TFD containing 100 mg of caffeine
Number of subjects: 32

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 32
Study: 34757657

Group type: EXPERIMENTAL
Intervention: Ensartinib (225 mg) after a high-fat, high-calorie meal
Number of subjects: 24
Study: 33309784

Group type: EXPERIMENTAL
Intervention: TENS
Number of subjects: 80

Group type: COMPARATOR
Intervention: Placebo-TENS
Number of subjects: 80
Study: 36206054

Group type: EXPERIMENTAL
Intervention: Remote ischemic conditioning (RIC) protocol consisting of four cycles of 5 min of leg ischemia
Number of subjects: 36

Group type: COMPARATOR
Intervention: Sham procedure
Number of subjects: 36
Study: 32826409

Group type: EXPERIMENTAL
Intervention: Maternal-administered NICU-based bundle of interventions
Number of subjects: 11
Study: 36416882

Group type: EXPERIMENTAL
Intervention: Smartphone-based out-of-hospital neonatal jaundice screening app
Number of subjects: 1424

Group type: COMPARATOR
Intervention: Routine care (control group)
Number of subjects: 1424
Study: 32758684

Group type: EXPERIMENTAL
Intervention: Fuji IX Gold Label (GC Corp)
Number of subjects: 150

Group type: EXPERIMENTAL
Intervention: Vitro Molar (nova DFL)
Number of subjects: 150

Group type: EXPERIMENTAL
Intervention: Maxxion R (FGM)
Number of subjects: 150

Group type: COMPARATOR
Intervention: Low-cost glass ionomers (Vitro Molar and Maxxion R)
Number of subjects: 150
Study: 36253284

Group type: EXPERIMENTAL
Intervention: SUGAR intervention with usual care
Number of subjects: 212

Group type: COMPARATOR
Intervention: Control (usual care)
Number of subjects: 212
Study: 33413104

Group type: EXPERIMENTAL
Intervention: TAP block with 15 ml (0.25%) ropivacaine on each side
Number of subjects: 159

Group type: COMPARATOR
Intervention: Placebo (no TAP block)
Number of subjects: 159
Study: 32574722

Group type: EXPERIMENTAL
Intervention: abiraterone + prednisone
Number of subjects: 547

Group type: EXPERIMENTAL
Intervention: enzalutamide
Number of subjects: 547

Group type: COMPARATOR
Intervention: abiraterone or enzalutamide
Number of subjects: 547
Study: 34758731

Group type: EXPERIMENTAL
Intervention: Ferric citrate hydrate (FC)
Number of subjects: 93

Group type: COMPARATOR
Intervention: Control (non-iron-based phosphate binder)
Number of subjects: 93
Study: 34942136

Group type: EXPERIMENTAL
Intervention: Risdiplam (5.00 mg for individuals ≥20 kg or 0.25 mg/kg for individuals <20 kg)
Number of subjects: 180

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 180

Group type: EXPERIMENTAL
Intervention: Risdiplam
Number of subjects: 180
Study: 32094459

Group type: EXPERIMENTAL
Intervention: PM2.5 (10 µg/m3 increase in 3-day moving average, lag 0-2)
Number of subjects: 0

Group type: EXPERIMENTAL
Intervention: Ozone (20 ppb increase in 3-day moving average, lag 0-2)
Number of subjects: 0
Study: 37365436

Group type: EXPERIMENTAL
Intervention: Relugolix plus E2 1 mg and NETA 0.5 mg
Number of subjects: 48

Group type: COMPARATOR
Intervention: Relugolix 40 mg alone
Number of subjects: 48
Study: 34410234

Group type: EXPERIMENTAL
Intervention: Thoracic spine manipulation along with conventional physical therapy
Number of subjects: 60

Group type: COMPARATOR
Intervention: Conventional physical therapy
Number of subjects: 60
Study: 34757340

Group type: EXPERIMENTAL
Intervention: Ultrasound-guided multiple nerve blocks (fascia iliaca compartment block+sacral plexus block+superior cluneal nerve block)
Number of subjects: 94

Group type: COMPARATOR
Intervention: General anesthesia
Number of subjects: 94

Group type: EXPERIMENTAL
Intervention: Ultrasound-guided multiple nerve blocks
Number of subjects: 94
Study: 32824394

Group type: EXPERIMENTAL
Intervention: Virtual Reality (VR) treatment group
Number of subjects: 44

Group type: COMPARATOR
Intervention: Exercise treatment group
Number of subjects: 44
Study: 34913256

Group type: EXPERIMENTAL
Intervention: Negative attitude to treatment
Number of subjects: 142

Group type: EXPERIMENTAL
Intervention: Perceived recovery
Number of subjects: 142

Group type: EXPERIMENTAL
Intervention: Quality of life
Number of subjects: 142

Group type: EXPERIMENTAL
Intervention: Attention
Number of subjects: 142
Study: 35025593

Group type: EXPERIMENTAL
Intervention: Deliberate practice (DP) training
Number of subjects: 109

Group type: COMPARATOR
Intervention: Control group (consultation training as usual)
Number of subjects: 109
Study: 33001314

Group type: EXPERIMENTAL
Intervention: Procalcitonin antimicrobial stewardship intervention
Number of subjects: 9
Study: 35906623

Group type: EXPERIMENTAL
Intervention: 61.2 Gy radiation dose with concurrent chemoradiotherapy (paclitaxel/cisplatin regimen for 2 cycles followed by consolidation chemotherapy for 2 cycles)
Number of subjects: 646

Group type: COMPARATOR
Intervention: 50.4 Gy radiation dose with concurrent chemoradiotherapy (paclitaxel/cisplatin regimen for 2 cycles followed by consolidation chemotherapy for 2 cycles)
Number of subjects: 646
Study: 34600308

Group type: EXPERIMENTAL
Intervention: Mantra meditation
Number of subjects: 31

Group type: COMPARATOR
Intervention: Classical music listening
Number of subjects: 31
Study: 32246153

Group type: EXPERIMENTAL
Intervention: Spaced formats of Prolonged Exposure (PE) or Present Centered Therapy
Number of subjects: 128

Group type: EXPERIMENTAL
Intervention: Massed format of Prolonged Exposure (PE)
Number of subjects: 128

Group type: COMPARATOR
Intervention: Baseline sleep disorder symptoms
Number of subjects: 128

Group type: COMPARATOR
Intervention: Short weekends/off days sleep
Number of subjects: 128
Study: 33896213

Group type: EXPERIMENTAL
Intervention: Sustained natural apophyseal glides
Number of subjects: 80

Group type: COMPARATOR
Intervention: Detuned laser (placebo)
Number of subjects: 80
Study: 37164603

Group type: EXPERIMENTAL
Intervention: Drug-Coated Balloon (DCB)
Number of subjects: 232

Group type: COMPARATOR
Intervention: Drug-Eluting Stent (DES)
Number of subjects: 232
Study: 33726777

Group type: EXPERIMENTAL
Intervention: Active Early Learning (AEL) program
Number of subjects: 314

Group type: COMPARATOR
Intervention: Usual practice care (control)
Number of subjects: 314
Study: 32667286

Group type: EXPERIMENTAL
Intervention: Selgantolimod 0.5 mg
Number of subjects: 71

Group type: EXPERIMENTAL
Intervention: Selgantolimod 1.5 mg
Number of subjects: 71

Group type: EXPERIMENTAL
Intervention: Selgantolimod 3 mg
Number of subjects: 71

Group type: EXPERIMENTAL
Intervention: Selgantolimod 5 mg
Number of subjects: 71

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 71

Group type: EXPERIMENTAL
Intervention: Food effect
Number of subjects: 71
Study: 35333492

Group type: EXPERIMENTAL
Intervention: Tislelizumab plus platinum-pemetrexed (arm T + PP)
Number of subjects: 332

Group type: COMPARATOR
Intervention: Platinum-pemetrexed alone (arm PP)
Number of subjects: 332
Study: 32444058

Group type: EXPERIMENTAL
Intervention: Cold water immersion for 10 minutes every night for 2 weeks
Number of subjects: 80

Group type: COMPARATOR
Intervention: Warm water immersion for 10 minutes every night for 2 weeks
Number of subjects: 80

Group type: EXPERIMENTAL
Intervention: Both interventions (cold and warm water)
Number of subjects: 80
Study: 35302551

Group type: EXPERIMENTAL
Intervention: Active Cycle of Breathing Technique (ACBT)
Number of subjects: 34

Group type: COMPARATOR
Intervention: Usual pre‐/postoperative breathing exercises
Number of subjects: 34
Study: 33319493

Group type: EXPERIMENTAL
Intervention: Co-ablation (CA)
Number of subjects: 81

Group type: COMPARATOR
Intervention: Argon-helium cryoablation (AHC)
Number of subjects: 81
Study: 35549980

Group type: EXPERIMENTAL
Intervention: Self-guided digital therapeutic application with exposure-based behavioral experiments in VR
Number of subjects: 40

Group type: COMPARATOR
Intervention: Control treatment
Number of subjects: 40
Study: 34291626

Group type: EXPERIMENTAL
Intervention: Multidisciplinary physical interventions (balance training, resistance training, cycling ergometer) in addition to standard cardiac rehabilitation (CR)
Number of subjects: 75

Group type: EXPERIMENTAL
Intervention: Multidisciplinary physical interventions
Number of subjects: 75

Group type: COMPARATOR
Intervention: Standard cardiac rehabilitation (CR)
Number of subjects: 75
Study: 32894117

Group type: EXPERIMENTAL
Intervention: Contracted endodontic cavity (CEC)
Number of subjects: 40

Group type: COMPARATOR
Intervention: Traditional endodontic cavity (TEC)
Number of subjects: 40
Study: 34419232

Group type: EXPERIMENTAL
Intervention: Text messaging interventions (4 different types with varying personalization, interactivity, and message frequency)
Number of subjects: 277
Study: 33202893

Group type: EXPERIMENTAL
Intervention: Strengthening exercise protocol for 9 weeks (two sessions of 40 min per week)
Number of subjects: 36

Group type: COMPARATOR
Intervention: Control group (no exercises)
Number of subjects: 36
Study: 33865648

Group type: EXPERIMENTAL
Intervention: Capsulotomy
Number of subjects: 98

Group type: COMPARATOR
Intervention: Capsulectomy
Number of subjects: 98
Study: 32282015

Group type: EXPERIMENTAL
Intervention: PASTA intervention
Number of subjects: 1214

Group type: COMPARATOR
Intervention: Standard care
Number of subjects: 1214
Study: 35149904

Group type: EXPERIMENTAL
Intervention: ZipBond X (ZBX) in self-etch mode (ZBX-SE)
Number of subjects: 64

Group type: EXPERIMENTAL
Intervention: Prime and Bond Active (PBA) in self-etch mode (PBA-SE)
Number of subjects: 64

Group type: EXPERIMENTAL
Intervention: Scotchbond Universal (SCH) in self-etch mode (SCH-SE)
Number of subjects: 64

Group type: EXPERIMENTAL
Intervention: Clearfil Universal Bond Quick (CQB) in self-etch mode (CQB-SE)
Number of subjects: 64

Group type: EXPERIMENTAL
Intervention: ZipBond X (ZBX) in etch-and-rinse mode (ZBX-ER)
Number of subjects: 64

Group type: EXPERIMENTAL
Intervention: Scotchbond Universal (SCH) in etch-and-rinse mode (SCH-ER)
Number of subjects: 64

Group type: EXPERIMENTAL
Intervention: Prime and Bond Active (PBA) in etch-and-rinse mode (PBA-ER)
Number of subjects: 64

Group type: EXPERIMENTAL
Intervention: Clearfil Universal Bond Quick (CQB) in etch-and-rinse mode (CQB-ER)
Number of subjects: 64
Study: 34776125

Group type: EXPERIMENTAL
Intervention: Kinesio Tape application on ankle (G1)
Number of subjects: 48

Group type: EXPERIMENTAL
Intervention: Kinesio Tape application on hamstrings (G2)
Number of subjects: 48
Study: 33407298

Group type: EXPERIMENTAL
Intervention: Male friendly clinic offering private, quick, supportive/sensitive and flexible service
Number of subjects: 62

Group type: EXPERIMENTAL
Intervention: Compensation to cover transport and opportunity cost for attending the clinic
Number of subjects: 62

Group type: COMPARATOR
Intervention: Peer pressure and fear of being seen at ANC
Number of subjects: 62

Group type: COMPARATOR
Intervention: Health system problems associated with ANC services organization
Number of subjects: 62

Group type: COMPARATOR
Intervention: Association between ANC and HIV testing services
Number of subjects: 62
Study: 35871420

Group type: EXPERIMENTAL
Intervention: Creative Expressive Arts‐based Storytelling (CrEAS)
Number of subjects: 135
Study: 33169345

Group type: EXPERIMENTAL
Intervention: Imeglimin 1000 mg
Number of subjects: 14

Group type: COMPARATOR
Intervention: Normal hepatic function (Control)
Number of subjects: 14
Study: 32845584

Group type: EXPERIMENTAL
Intervention: Tazarotene 0.045% lotion
Number of subjects: 1614
Study: 35380672

Group type: EXPERIMENTAL
Intervention: Real bilateral tDCS (anodal right/cathodal left)
Number of subjects: 42

Group type: COMPARATOR
Intervention: Sham tDCS
Number of subjects: 42
Study: 34598981

Group type: EXPERIMENTAL
Intervention: Web-based complex intervention on relapse management
Number of subjects: 188
Study: 32275365

Group type: EXPERIMENTAL
Intervention: Electroacupuncture (EA) at governor vessel combined with donepezil hydrochloride (5 mg/day, increased to 10 mg/day after 4 weeks if needed) for 8 weeks.
Number of subjects: 60

Group type: COMPARATOR
Intervention: Donepezil hydrochloride alone (5 mg/day, increased to 10 mg/day after 4 weeks if needed) for 8 weeks.
Number of subjects: 60
Study: 34043898

Group type: EXPERIMENTAL
Intervention: Video-based cognitive-behavioral intervention (nine 15-20 minute sessions, three days a week for three weeks)
Number of subjects: 150

Group type: EXPERIMENTAL
Intervention: Video-based cognitive-behavioral intervention
Number of subjects: 150

Group type: COMPARATOR
Intervention: Waiting list control
Number of subjects: 150
Study: 32428549

Group type: EXPERIMENTAL
Intervention: DRN-DCMB model
Number of subjects: 207
Study: 35365412

Group type: EXPERIMENTAL
Intervention: TAP flap
Number of subjects: 50

Group type: COMPARATOR
Intervention: LD flap
Number of subjects: 50
Study: 33857327

Group type: EXPERIMENTAL
Intervention: Everolimus 10 mg/d
Number of subjects: 308

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 308
Study: 32222857

Group type: EXPERIMENTAL
Intervention: SBM25
Number of subjects: 200

Group type: EXPERIMENTAL
Intervention: SBM50
Number of subjects: 200

Group type: EXPERIMENTAL
Intervention: SBM75
Number of subjects: 200

Group type: COMPARATOR
Intervention: SBM0
Number of subjects: 200

Group type: EXPERIMENTAL
Intervention: SBM100
Number of subjects: 200
Study: 35786578

Group type: EXPERIMENTAL
Intervention: XP Finisher
Number of subjects: 75

Group type: EXPERIMENTAL
Intervention: XP Finisher R
Number of subjects: 75

Group type: COMPARATOR
Intervention: Passive Ultrasonic Irrigation
Number of subjects: 75
Study: 35470860

Group type: EXPERIMENTAL
Intervention: Quit Genius (digital clinician‐assisted CBT intervention)
Number of subjects: 556

Group type: COMPARATOR
Intervention: Very Brief Advice (VBA)
Number of subjects: 556

Group type: EXPERIMENTAL
Intervention: Quit Genius
Number of subjects: 556
Study: 34580704

Group type: EXPERIMENTAL
Intervention: In-hospital delay to surgery of less than 8 hours
Number of subjects: 1800

Group type: COMPARATOR
Intervention: In-hospital delay to surgery of less than 24 hours
Number of subjects: 1800

Group type: EXPERIMENTAL
Intervention: Antibiotics while waiting for surgery
Number of subjects: 1800

Group type: COMPARATOR
Intervention: No antibiotics while waiting for surgery
Number of subjects: 1800

Group type: EXPERIMENTAL
Intervention: Length of hospital stay
Number of subjects: 1800

Group type: EXPERIMENTAL
Intervention: 30-day complications graded using Clavien-Dindo classification
Number of subjects: 1800

Group type: EXPERIMENTAL
Intervention: Preoperative pain
Number of subjects: 1800

Group type: EXPERIMENTAL
Intervention: Conversion rate
Number of subjects: 1800

Group type: EXPERIMENTAL
Intervention: Histopathological diagnosis
Number of subjects: 1800

Group type: EXPERIMENTAL
Intervention: Sunshine Appendicitis Grading System classification
Number of subjects: 1800
Study: 35645167

Group type: EXPERIMENTAL
Intervention: as-needed budesonide-formoterol (BFM) (160/4.5 μg)
Number of subjects: 31

Group type: COMPARATOR
Intervention: budesonide (BUD) (200 μg) twice daily
Number of subjects: 31

Group type: EXPERIMENTAL
Intervention: as-needed budesonide-formoterol (BFM)
Number of subjects: 31

Group type: COMPARATOR
Intervention: budesonide (BUD)
Number of subjects: 31
Study: 32590084

Group type: EXPERIMENTAL
Intervention: Blood transfusion
Number of subjects: 12547
Study: 34894712

Group type: EXPERIMENTAL
Intervention: Using less thickener (pudding vs nectar)
Number of subjects: 202

Group type: EXPERIMENTAL
Intervention: Diet types (pureed, soft, mixed, regular)
Number of subjects: 202

Group type: COMPARATOR
Intervention: Home vs Nursing Home residence
Number of subjects: 202

Group type: COMPARATOR
Intervention: Fears (Home vs Nursing Home)
Number of subjects: 202

Group type: COMPARATOR
Intervention: Mental health (Home vs Nursing Home)
Number of subjects: 202

Group type: COMPARATOR
Intervention: Food selection (Home vs Nursing Home)
Number of subjects: 202
Study: 35987543

Group type: EXPERIMENTAL
Intervention: Cognitive bias modification, interpretation retraining (CBM‐I)
Number of subjects: 167

Group type: COMPARATOR
Intervention: Guided visualization relaxation training
Number of subjects: 167
Study: 32044165

Group type: EXPERIMENTAL
Intervention: Irradiation to PTVelect up to EQD2 of 40 Gy
Number of subjects: 200

Group type: COMPARATOR
Intervention: Irradiation to PTVelect up to EQD2 of 50 Gy
Number of subjects: 200
Study: 35082352

Group type: EXPERIMENTAL
Intervention: MF-myofascial release
Number of subjects: 60

Group type: EXPERIMENTAL
Intervention: E-exercise program
Number of subjects: 60

Group type: EXPERIMENTAL
Intervention: MFE-myofascial release and exercise program
Number of subjects: 60

Group type: COMPARATOR
Intervention: C-no intervention
Number of subjects: 60
Study: 33902160

Group type: EXPERIMENTAL
Intervention: Chest CT findings
Number of subjects: 89
Study: 35731318

Group type: EXPERIMENTAL
Intervention: Open access (OA) program
Number of subjects: 120

Group type: COMPARATOR
Intervention: RCT program
Number of subjects: 120
Study: 34333388

Group type: EXPERIMENTAL
Intervention: Algae ingredient (0.175%) in diet during Eimeria challenge
Number of subjects: 1200

Group type: EXPERIMENTAL
Intervention: Algae ingredient (0.175%) in diet, unchallenged
Number of subjects: 1200

Group type: COMPARATOR
Intervention: Control diet (no algae ingredient)
Number of subjects: 1200
Study: 32079739

Group type: EXPERIMENTAL
Intervention: Ultrasound-guided rhomboid intercostal block with 30 mL 0.25% bupivacaine
Number of subjects: 0

Group type: COMPARATOR
Intervention: Control group (no block intervention)
Number of subjects: 0
Study: 36328447

Group type: EXPERIMENTAL
Intervention: Melinjo seed extract
Number of subjects: 0

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 0
Study: 33478482

Group type: EXPERIMENTAL
Intervention: Curcumin extract (Curcugen™) 500 mg once daily for 8 weeks
Number of subjects: 79

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 79
Study: 36151976

Group type: EXPERIMENTAL
Intervention: Comfort‐in™ injection system (CIS)
Number of subjects: 48

Group type: COMPARATOR
Intervention: Traditional anesthesia (TA)
Number of subjects: 48
Study: 33586796

Group type: EXPERIMENTAL
Intervention: Muscle-sparing lateral thoracotomy (MSLT)
Number of subjects: 28

Group type: COMPARATOR
Intervention: Standard lateral thoracotomy (SLT)
Number of subjects: 28

Group type: EXPERIMENTAL
Intervention: Both MSLT and SLT
Number of subjects: 28
Study: 34470496

Group type: EXPERIMENTAL
Intervention: Tirofiban
Number of subjects: 30

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 30
Study: 33245858

Group type: EXPERIMENTAL
Intervention: Prednisone (100 mg oral for 5 days, tapering 20 mg every 3 days for a total of 17 days)
Number of subjects: 116

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 116
Study: 36114520

Group type: EXPERIMENTAL
Intervention: Cognitive Enhancement Therapy
Number of subjects: 0

Group type: COMPARATOR
Intervention: Social Skills Training
Number of subjects: 0
Study: 33538638

Group type: EXPERIMENTAL
Intervention: Bremelanotide
Number of subjects: 250

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 250
Study: 32776664

Group type: EXPERIMENTAL
Intervention: Endovascular therapy (EVT) for AIS
Number of subjects: 166